-
1تقرير
المؤلفون: Genentech, Inc.
المساهمون: Dr. Neil M. Bressler, Principal Investigator
المصدر: Chang MA, Do DV, Bressler SB, Cassard SD, Gower EW, Bressler NM. Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration. Retina. 2010 Sep;30(8):1171-6. doi: 10.1097/IAE.0b013e3181dd6d8a.
Ranibizumab in Hemorrhagic Choroidal Neovascularization Trialالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00363168Test
-
2تقرير
المؤلفون: Genentech, Inc.
المساهمون: Dr. Neil M. Bressler, Principal Investigator
المصدر: Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00378196Test